Medication liability exposure: what claims managers need to know

Identify and manage medication-related liability risks in your insurance claims portfolio

Published: 3 April 2026 | Updated: 3 April 2026

Medication as an underappreciated liability risk

Claims managers typically focus on liability exposure related to medical treatment, vocational decisions, or return-to-work planning. Medication, however, represents a significant but often overlooked source of liability exposure. When medication decisions go wrong, they can trigger costly adverse events, complaints, regulatory scrutiny, or even litigation. Your role is not to manage medication decisions directly, but to understand medication liability exposure and ensure appropriate governance is in place.

Medication liability can arise from several sources: inappropriate medication selection, inadequate monitoring, failure to identify or manage side effects, medication interactions, dependence issues, or decisions about coverage and duration. Managing this exposure requires systematic monitoring and prompt engagement of specialist expertise when risks emerge.

Understanding medication liability categories

Medication liability exposure falls into several distinct categories, each with different risk profiles and management approaches:

1. Inappropriate medication selection or dosing

When a claimant receives a medication inappropriate for their condition, age, or clinical context, liability exposure emerges. Examples include:

• Sedating antidepressants prescribed to a claimant with high fall risk, resulting in fall and fracture
• High-dose opioids prescribed despite documented addiction history
• NSAIDs prescribed without gastroprotection despite ulcer history
• Benzodiazepines prescribed to older claimants with cognitive impairment

Your liability exposure exists even when the treating provider made the prescribing decision, because your approval or continued funding of inappropriate medications implicates your claims management process.

2. Medication interaction or polypharmacy complications

When multiple medications create dangerous interactions or compounded side effects, liability emerges. Common scenarios include:

• Serotonin syndrome from medication combinations
• Excessive sedation from overlapping sedatives
• Cardiovascular complications from drug interactions
• Renal or hepatic complications from medication combinations

Polypharmacy is particularly high-risk because each new medication exponentially increases interaction risk. Claims with five or more medications have substantially higher adverse event risk than simpler regimens.

3. Medication dependence and withdrawal complications

Medications with dependence liability (benzodiazepines, opioids, some antidepressants) create ongoing liability exposure. Issues arise from:

• Prolonged medication use without clear indication or exit strategy
• Claimant developing physical or psychological dependence
• Withdrawal complications when medications are reduced or ceased
• Claimants requesting medication escalation despite questionable clinical justification

Your liability grows if you fund medications with dependence liability long-term without documented plan for eventual cessation or structured withdrawal management.

4. Failure to identify or manage medication side effects

When claimants experience medication side effects that impair their safety or recovery, and these are not identified or addressed, liability exposure emerges. Examples:

• Medication-induced cognitive impairment preventing rehabilitation participation, unrecognised for months
• Medication-related falls causing additional injury, despite early warning signs
• Medication-induced mood changes misattributed to the injury rather than the drug
• Medication allergies or hypersensitivity reactions not properly documented or managed

5. Inadequate informed consent or communication

Medication liability can arise when claimants do not understand the medications they are taking, the expected duration, or the plan for eventual cessation. Issues include:

• Claimants unaware that medications are temporary or intended for short-term use only
• Side effects not explained or downplayed, leading to claimant distrust or non-adherence
• Claimants surprised by sudden medication cessation without prior communication
• Lack of documentation that medication decisions were explained and understood

Identifying medication liability risks in your claims

Develop a systematic screening process to identify high-liability medication situations:

Managing medication liability through appropriate governance

Reduce your medication liability exposure by implementing standard governance practices:

1. Establish medication monitoring protocols

Build medication review into your regular claims monitoring. For higher-risk claims, establish quarterly or semi-annual medication reviews. Document in your claims file:

• Current medication list with indications and start dates
• Any side effects or concerns reported by the claimant
• Assessments of ongoing necessity for each medication
• Plans for medication duration, adjustment, or cessation
• Specialist medical input on medication appropriateness

2. Engage specialist medication expertise early

When high-risk medication situations emerge, engage specialist pharmacy expertise rather than addressing in isolation. Specialist involvement demonstrates appropriate governance and provides defence against later criticism. For example, if a claimant expresses concerns about sedating medications, arrange pharmacy review rather than dismissing the concerns or waiting for complications.

3. Establish clear medication duration and reduction plans

For medications with dependence liability or those prescribed for acute conditions, establish explicit plans for eventual cessation:

• Benzodiazepines: Plan cessation within 8-12 weeks of initiation; document taper protocol
• Acute pain medications: Establish target for return to non-opioid pain management within 12 weeks
• Temporary antidepressants: Document planned duration and criteria for continuation beyond initial period

4. Document medication decisions carefully

Your claims file documentation protects you against later liability claims. Ensure you document:

• Dates medications were approved or continued
• Clinical justification for medications, particularly high-risk ones
• Any concerns about appropriateness or side effects
• Specialist input obtained on medication questions
• Plans for medication adjustment or cessation
• Communication with claimant about medication use, side effects, and plans

5. Address medication side effects and adverse events promptly

When claimants report medication side effects, address them immediately rather than dismissing or delaying. Document your response:

• Side effect reported on [date]
• Medical review arranged with [provider] on [date]
• Recommendation: [medication adjustment/specialist review/cease medication]
• Action taken: [implementation date and details]

6. Communicate medication decisions clearly

Ensure claimants understand:

• Why each medication is prescribed
• Expected duration and plan for eventual cessation
• Known side effects and how to report concerning symptoms
• What to do if they have concerns about medications

Poor communication about medications increases complaint risk and erodes claimant trust. Clear communication serves both claimant interests and your liability protection.

Managing specific high-liability medication categories

Benzodiazepines

Benzodiazepines have substantial liability exposure due to dependence risk, fall risk, and cognitive impairment. Management approach:

• Approve only for short-term acute use (8-12 weeks maximum)
• Require documented taper plan at initiation
• Monitor adherence to taper schedule
• Address withdrawal symptoms with structured support rather than extending use
• Document that dependence risk was discussed with claimant

Opioid medications

Opioid liability has increased significantly due to addiction and overdose risks. Management approach:

• Require specialist pain management assessment for long-term opioid use
• Establish maximum duration for acute post-injury opioid use (typically 8-12 weeks)
• For long-term opioid use, require documented criteria: failed alternative treatments, documented benefit, addiction risk screening
• Monitor for addiction signs and appropriately adjust prescribing
• Require regular reassessment of ongoing necessity
• Document discussions with claimant about addiction risks

Polypharmacy regimens

Claims on five or more medications have substantially higher adverse event risk. Management approach:

• Screen for polypharmacy at regular claims reviews
• Request specialist medication review for all claims on 5+ medications
• Implement recommendations for medication reduction or simplification
• Monitor for drug interactions and side effects more closely
• Establish target for reduction to fewer, more essential medications

Medications with cognitive effects

Medications impairing cognition can prevent rehabilitation participation and represent liability for delayed recovery. Management approach:

• Identify medications with cognitive side effects
• Assess whether cognitive effects are interfering with rehabilitation or work retraining
• If cognitive impairment limits recovery, initiate deprescribing plan
• Document that medication-induced cognitive impairment was identified and addressed

Documentation best practices for liability protection

Your claims file is your primary defence against medication liability claims. Use this documentation framework:

Building a medication risk culture

The most effective liability management approach is building a claims management culture that treats medication appropriateness as a priority. This means:

• Regular training for claims staff on medication liability risks
• Medication review as a standard part of claims monitoring, not an exception
• Specialist medication expertise engaged routinely, not only in crisis
• Medication questions addressed promptly rather than deferred
• Documentation of medication decisions as standard practice
• Claimant communication about medications as explicit claims responsibility

Your role in medication liability management

You are not a pharmacist or physician, but you are responsible for ensuring medication decisions are appropriate and monitored. This means understanding your claims' medication risk profile, intervening when risks emerge, and engaging specialist expertise as needed. Proactive medication management is both good clinical practice and excellent claims management from a liability perspective.